Accord Biopharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire Udenyca® (Pegfilgrastim-Cbqv) Business From Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
Accord生物制药宣布,Intas制药有限公司将收购Udenyca®(Pegfilgrastim-Cbqv)业务,从Coherus BioSciences公司,为继续美国增长释放潜力